Proteomics and genomics share the common goal of characterizing biological systems, yet they differ fundamentally in their molecular targets, analytical challenges and interpretive value. Genomics ...
The first-in-human phase 1/2 study of TSN1611, a highly selective KRAS G12D inhibitor, in patients with advanced solid tumors. Seizure-related homolog 6 (SEZ6) expression and ctDNA methylation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback